{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T16:47:40Z","timestamp":1775062060460,"version":"3.50.1"},"reference-count":33,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2007,1,1]],"date-time":"2007-01-01T00:00:00Z","timestamp":1167609600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["NeuroToxicology"],"published-print":{"date-parts":[[2007,1]]},"DOI":"10.1016\/j.neuro.2006.06.002","type":"journal-article","created":{"date-parts":[[2006,6,14]],"date-time":"2006-06-14T13:17:20Z","timestamp":1150291040000},"page":"27-32","source":"Crossref","is-referenced-by-count":15,"title":["Cytotoxicity of 17 tetrahydroisoquinoline derivatives in SH-SY5Y human neuroblastoma cells is related to mitochondrial NADH\u2013ubiquinone oxidoreductase inhibition"],"prefix":"10.1016","volume":"28","author":[{"given":"Yaichiro","family":"Kotake","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoko","family":"Sekiya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katsuhiro","family":"Okuda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shigeru","family":"Ohta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuro.2006.06.002_bib1","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1111\/j.1471-4159.1992.tb11012.x","article-title":"Effects of several cations on the neuronal uptake of dopamine and the specific binding of [3H]GBR 12783: attempts to characterize the Na+ dependence of the neuronal transport of dopamine","volume":"59","author":"Amejdki-Chab","year":"1992","journal-title":"J Neurochem"},{"key":"10.1016\/j.neuro.2006.06.002_bib2","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1111\/j.1471-4159.1987.tb05752.x","article-title":"Biochemical and pharmacological characterization of [3H]GBR 12935 binding in vitro to rat striatal membranes: labeling of the dopamine uptake complex","volume":"48","author":"Andersen","year":"1987","journal-title":"J Neurochem"},{"key":"10.1016\/j.neuro.2006.06.002_bib3","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1021\/jm00126a016","article-title":"Phencyclidine-like effects of tetrahydroisoquinolines and related compounds","volume":"32","author":"Gray","year":"1989","journal-title":"J Med Chem"},{"key":"10.1016\/j.neuro.2006.06.002_bib4","first-page":"11","article-title":"Preparation and properties of NADH:ubiquinone oxidoreductase (complex I). EC 1.6.5.3","volume":"53","author":"Hatefi","year":"1978"},{"key":"10.1016\/j.neuro.2006.06.002_bib5","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1016\/S0960-894X(00)00326-7","article-title":"Inhibition of dopamine receptors by endogenous amines: binding to striatal receptors and pharmacological effects on locomotor activity","volume":"10","author":"Kawai","year":"2000","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.neuro.2006.06.002_bib6","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1021\/tx000047y","article-title":"Dopamine transporter and catechol-O-methyltransferase activities are required for the toxicity of 1-(3\u2032,4\u2032-dihydroxybenzyl)-l,2,3,4-tetrahydroisoquinoline","volume":"13","author":"Kawai","year":"2000","journal-title":"Chem Res Toxicol"},{"key":"10.1016\/j.neuro.2006.06.002_bib7","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1046\/j.1471-4159.1998.70020745.x","article-title":"Novel endogenous 1,2,3,4-tetrahydroisoquinoline derivatives: uptake by dopamine transporter and activity to induce parkinsonism","volume":"70","author":"Kawai","year":"1998","journal-title":"J Neurochem"},{"key":"10.1016\/j.neuro.2006.06.002_bib8","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/0006-291X(86)91111-3","article-title":"Tetrahydroisoquinoline and 1-methyl-tetrahydroisoquinoline as novel endogenous amines in rat brain","volume":"140","author":"Kohno","year":"1986","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.neuro.2006.06.002_bib9","doi-asserted-by":"crossref","first-page":"2507","DOI":"10.2174\/0929867033456558","article-title":"MPP+ analogs acting on mitochondria and inducing neuro-degeneration","volume":"10","author":"Kotake","year":"2003","journal-title":"Curr Med Chem"},{"key":"10.1016\/j.neuro.2006.06.002_bib10","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0306-4522(02)00789-3","article-title":"Neurotoxicity of an endogenous brain amine, 1-benzyl-l,2,3,4-tetrahydroisoquinoline in organotypic slice co-culture of mesencephalon and striatum","volume":"117","author":"Kotake","year":"2003","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuro.2006.06.002_bib11","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.brainres.2004.11.019","article-title":"Neuroprotective effect of 1-methyl-1,2,3,4-tetrahydroisoquinoline on cultured rat mesencephalic neurons in the presence or absence of various neurotoxins","volume":"1033","author":"Kotake","year":"2005","journal-title":"Brain Res"},{"key":"10.1016\/j.neuro.2006.06.002_bib12","doi-asserted-by":"crossref","first-page":"2633","DOI":"10.1046\/j.1471-4159.1995.65062633.x","article-title":"1-Benzyl-l,2,3,4-tetrahydroisoquinoline as a parkinsonism-inducing agent: a novel endogenous amine in mouse brain and parkinsonian CSF","volume":"65","author":"Kotake","year":"1995","journal-title":"J Neurochem"},{"key":"10.1016\/j.neuro.2006.06.002_bib13","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/0304-3940(96)13065-2","article-title":"Chronic administration of 1-benzyl-1,2,3,4-tetrahydroisoquinoline, an endogenous amine in the brain, induces parkinsonism in a primate","volume":"217","author":"Kotake","year":"1996","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.neuro.2006.06.002_bib14","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1126\/science.6823561","article-title":"Chronic parkinsonism in humans due to a product of meperidine-analog synthesis","volume":"219","author":"Langston","year":"1983","journal-title":"Science"},{"key":"10.1016\/j.neuro.2006.06.002_bib15","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1146\/annurev.bi.38.070169.005015","article-title":"Oxidative phosphorylation in mitochondria","volume":"38","author":"Lardy","year":"1969","journal-title":"Annu Rev Biochem"},{"key":"10.1016\/j.neuro.2006.06.002_bib16","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0021-9258(19)52451-6","article-title":"Protein measurement with the Folin phenol reagent","volume":"193","author":"Lowry","year":"1951","journal-title":"J Biol Chem"},{"key":"10.1016\/j.neuro.2006.06.002_bib17","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1111\/j.1471-4159.1990.tb04585.x","article-title":"A novel and neurotoxic tetrahydroisoquinoline derivative in vivo: formation of l,3-dimethyl-l,2,3,4-tetrahydroisoquinoline, a condensation product of amphetamines, in brains of rats under chronic ethanol treatment","volume":"55","author":"Makino","year":"1990","journal-title":"J Neurochem"},{"key":"10.1016\/j.neuro.2006.06.002_bib18","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S0014-2999(98)00131-9","article-title":"Structural significance of azaheterocyclic amines related to Parkinson's disease for dopamine transporter","volume":"348","author":"Matsubara","year":"1998","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.neuro.2006.06.002_bib19","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1016\/S0006-2952(98)00142-7","article-title":"Isoquinoline derivatives as endogenous neurotoxins in the etiology of Parkinson's disease","volume":"56","author":"McNaught","year":"1998","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.neuro.2006.06.002_bib20","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1016\/0006-2952(95)02086-1","article-title":"Inhibition of complex I by isoquinoline derivatives structurally related to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)","volume":"27","author":"McNaught","year":"1995","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.neuro.2006.06.002_bib21","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/0304-3940(96)12419-8","article-title":"Toxicity to PC12 cells of isoquinoline derivatives structurally related to 1-methyl-4-phenyl-l,2,3,6-tetrahydropyridine","volume":"206","author":"McNaught","year":"1996","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.neuro.2006.06.002_bib22","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1016\/0006-2952(96)00091-3","article-title":"Effects of isoquinoline derivatives structurally related to 1-methyl-4-phenyl-l,2,3,6-tetrahydropyridine (MPTP) on mitochondrial respiration","volume":"51","author":"McNaught","year":"1996","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.neuro.2006.06.002_bib23","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/0006-2952(96)00133-5","article-title":"Inhibition of [3H]dopamine uptake into striatal synaptosomes by isoquinoline derivatives structurally related to 1-methyl-4-phenyl-l,2,3,6-tetrahydropyridine","volume":"52","author":"McNaught","year":"1996","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.neuro.2006.06.002_bib24","doi-asserted-by":"crossref","first-page":"S99","DOI":"10.1002\/ana.410440715","article-title":"Mitochondrial dysfunction in Parkinson's disease","volume":"44","author":"Mizuno","year":"1998","journal-title":"Ann Neurol"},{"key":"10.1016\/j.neuro.2006.06.002_bib25","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1007\/s007020050087","article-title":"Effects of various tetrahydroisoquinoline derivatives on mitochondrial respiration and the electron transfer complexes","volume":"105","author":"Morikawa","year":"1998","journal-title":"J Neural Transm"},{"key":"10.1016\/j.neuro.2006.06.002_bib26","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0168-0102(97)00083-7","article-title":"Isoquinoline neurotoxins in the brain and Parkinson's disease","volume":"29","author":"Nagatsu","year":"1997","journal-title":"Neurosci Res"},{"key":"10.1016\/j.neuro.2006.06.002_bib27","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1002\/ana.410260606","article-title":"Abnormalities of the electron transport chain in idiopathic Parkinson's disease","volume":"26","author":"Parker","year":"1989","journal-title":"Ann Neurol"},{"key":"10.1016\/j.neuro.2006.06.002_bib28","doi-asserted-by":"crossref","first-page":"2142","DOI":"10.1111\/j.1471-4159.1990.tb05809.x","article-title":"Anatomic and disease specificity of NADH COQ1 reductase (complex I) deficiency in Parkinson's disease","volume":"55","author":"Schapira","year":"1990","journal-title":"J Neurochem"},{"key":"10.1016\/j.neuro.2006.06.002_bib29","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1016\/S0006-2952(01)00922-4","article-title":"Selective dopaminergic neurotoxicity of isoquinoline derivatives related to Parkinson's disease: studies using heterologous expression systems of the dopamine transporter","volume":"63","author":"Storch","year":"2002","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.neuro.2006.06.002_bib30","doi-asserted-by":"crossref","first-page":"1940","DOI":"10.1111\/j.1471-4159.1991.tb06407.x","article-title":"1-Methyl-l,2,3,4-tetrahydroisoquinoline, decreasing in 1-methyl-4-phenyl-l,2,3,6-tetrahydropyridine-treated mouse, prevents parkinsonism-like behavior abnormalities","volume":"57","author":"Tasaki","year":"1991","journal-title":"J Neurochem"},{"key":"10.1016\/j.neuro.2006.06.002_bib31","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1111\/j.1471-4159.1993.tb13610.x","article-title":"Advances in our understanding of the mechanisms of the neurotoxicity of MPTP and related compounds","volume":"61","author":"Tipton","year":"1993","journal-title":"J Neurochem"},{"issue":"Suppl 8","key":"10.1016\/j.neuro.2006.06.002_bib32","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0040-4020(01)82177-3","article-title":"Synthesis of 6,7-dihydroxy-l,2,3,4-tetrahydroisoquinoline derivatives","volume":"22","author":"Yamato","year":"1966","journal-title":"Tetrahedron"},{"key":"10.1016\/j.neuro.2006.06.002_bib33","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/0304-3940(90)90768-5","article-title":"Parkinsonism in monkeys produced by chronic administration of an endogenous substance of the brain, tetrahydroisoquinoline: the behavioral and biochemical changes","volume":"119","author":"Yoshida","year":"1990","journal-title":"Neurosci Lett"}],"container-title":["NeuroToxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161813X06001653?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161813X06001653?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,7,28]],"date-time":"2021-07-28T09:39:14Z","timestamp":1627465154000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0161813X06001653"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,1]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2007,1]]}},"alternative-id":["S0161813X06001653"],"URL":"https:\/\/doi.org\/10.1016\/j.neuro.2006.06.002","relation":{},"ISSN":["0161-813X"],"issn-type":[{"value":"0161-813X","type":"print"}],"subject":[],"published":{"date-parts":[[2007,1]]}}}